News

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the Biogen’s Alzheimer’s disease treatment Aduhelm — along with other drugs like it — to clinical trials. Michelle McMurry-Heath, M.D., Ph.D., president and CEO of... Continue Reading

NCBIO forum explores moving technology through funding phases

A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology... Continue Reading

NCBIO Roadmap to Diversity event offers guidance for member DEI initiatives

Laura Gunter, Neil Jones, Celeste Warren and Shaylah Nunn-Jones NCBIO members gathered at the NC Biotechnology Center Wednesday, March 9, to seek inspiration and guidance in pursuing their companies’ diversity, equity and inclusion goals. Some key takeaways from the... Continue Reading

Biotech joins efforts to aid in humanitarian relief in Ukraine

The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications to the people of Ukraine. "The conflict in Ukraine and violence from Russia defies international law, norms and modern sensibilities,” said BIO President... Continue Reading

BMF presenters share lessons learned commissioning facilities during pandemic

At the NCBIO Biotech Manufacturers Forum held online Feb. 23, representatives from FUJIFILM Diosynth Biotechnologies, Lilly and Project Farma shared what they had learned about commissioning new facilities and equipment during the during the COVID-19 pandemic. Presenting at the meeting were... Continue Reading

Life Science Caucus tours NC Reseach Campus in Kannapolis

Life Science Caucus tours NC Reseach Campus in Kannapolis Members of the NC Life Science Caucus toured the NC Research Campus in Kannapolis on Wednesday, Feb. 23, along with local leaders and representatives of industry, such as Eli Lilly and Company, which is setting up shop in nearby... Continue Reading

Rep. Ross discusses immigration, IP, workforce and more with NCBIO members

Rep. Deborah Ross answers questions from NCBIO members Feb. 14 at NCBiotech. Immigration reform, protection of intellectual property, the threat of antimicrobial resistance, workforce training and more were topics covered by Rep. Deborah Ross at an NCBIO legislative round table held Monday,... Continue Reading

New report outlines best practices in bioscience economic development

The Biotechnology Innovation Organization, in partnership with the Council of State Bioscience Associations, released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best Practices in State and Regional... Continue Reading

Sen. Tillis joins NCBIO members for Q&A

Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North... Continue Reading

Who pays to create new medicines?

Who pays to create new medicines? The share of private money invested in developing new medicines approved by the FDA in 2020 exceeded the entire budget of the National Institutes of Health by about 6,500%, according to a new study by Vital Transformation. Vital Transformation... Continue Reading

NCBIO forum explores ways to improve recruitment and experience for patients in clinical trials

Patients and research organizations came together at the NCBIO Clinical Trials Forum to talk about ways to make recruiting and retaining patients easier for clinical trials. The forum was held Wednesday, Dec. 8 at the NC Biotechnology Center. Matthew Roberts, practice group leader, health care... Continue Reading

Laura Gunter named to Council of State Bioscience Associations board

Laura Gunter, NCBIO president NCBIO President Laura Gunter has been elected to the Board of Directors of the Council of State Bioscience Associations. Gunter will serve a two-year term beginning 2022. “We are thrilled to announce our new slate of incredibly accomplished and esteemed... Continue Reading